Company Profiles

driven by the PitchBook Platform

ADC Biotechnology

ADC Biotechnology
2010 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
PE Growth LATEST DEAL TYPE
$1.51M TOTAL AMOUNT RAISED
6 INVESTORS
Description

Developer of new process technology designed to offer new antibody drug conjugates. The company's new process technology delivers chemotherapy drugs, targeting specific cancer cells where they are internalized prior to release of the drugs as well as speeds, simplifies and significantly lower the costs of the conjugation processes, providing consumers with new antibody drug conjugate and anti-cancer therapies.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
OpTIC Technium, Ffordd William Morgan
Saint Asaph Business Park, Denbighshire
Saint Asaph LL17 0JD
Wales

+44 (0)17 4553 5241
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ADC Biotechnology’s full profile, request a free trial.

ADC Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. PE Growth/Expansion 25-Sep-2017 $1.51M Completed Startup
5. Grant 25-Sep-2017 00.000 Completed Startup
4. Early Stage VC 16-Jan-2013 00000 00.000 Completed Startup
3. Grant 09-Dec-2011 00000 00000 Completed Startup
2. Early Stage VC 09-Dec-2011 $546k $546k $1.48M Completed Startup
1. Seed Round 01-Sep-2010 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

ADC Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
B Ordinary 0,000 000.0 000.0 00 000.0 0.000
A Ordinary 0,000 000.0 000.0 00 000.0 00.000
To view this company’s complete Cap Table request access »

ADC Biotechnology Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Acceleris Capital Other Minority 000 0000 000000 0
Denbighshire County Council Government 000 0000 000000 0
Finance Wales PE/Buyout Minority 000 0000 000000 0
Maven Capital Partners PE/Buyout Minority 000 0000 000000 0
Seneca Partners UK PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

ADC Biotechnology Executive Team (3)

Name Title Board
Seat
Contact
Info
Charles Johnson Board Member & Chief Executive Officer
David Evans Ph.D Board Member, Chief Technology Officer & Founder
Colin McKee Head, Technical Services

You’re viewing 3 of 3 executives.

ADC Biotechnology Board Members (3)

Name Representing Role Since Contact
Info
Charles Johnson ADC Biotechnology Board Member & Chief Executive Officer 000 0000
David Evans Ph.D ADC Biotechnology Board Member, Chief Technology Officer & Founder 000 0000
Peter Jackson Ph.D Self Chairman 000 0000

You’re viewing 3 of 3 board members.